The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
Open accessAbstract
Background and purpose: The ability of cannabinoids to suppress mechanical hypersensitivity (mechanical allodynia) induced by treatment with the chemotherapeutic agent vincristine was evaluated in rats. Sites of action were subsequently identified. Experimental approach: Mechanical hypersensitivity developed over the course of ten daily injections of vincristine relative to groups receiving saline at the same times. Effects of the CB 1/CB 2 receptor agonist WIN55,212‐2, the receptor‐inactive enantiomer WIN55,212‐3, the CB 2‐selective agonist (R,S)‐AM1241, the opiate agonist morphine and vehicle on chemotherapy‐induced neuropathy were evaluated. WIN55,212‐2 was administered intrathecally (i.t.) or locally in the hindpaw to identify sites of action. Pharmacological specificity was established using competitive antagonists for CB 1 (SR141716) or CB 2 receptors (SR144528). Key results: Systemic administration of WIN55,212‐2, but not WIN55,212‐3, suppressed vincristine‐evoked mechanical allodynia. A leftward shift in the dose‐response curve was observed following WIN55,212‐2 relative to morphine treatment. The CB 1 (SR141716) and CB 2 (SR144528) antagonists blocked the anti‐allodynic effects of WIN55,212‐2. (R,S)‐AM1241 suppressed vincristine‐induced mechanical hypersensitivity through a CB 2 mechanism. Both cannabinoid agonists suppressed vincristine‐induced mechanical hypersensitivity without inducing catalepsy. Spinal sites of action are implicated in cannabinoid modulation of chemotherapy‐induced neuropathy. WIN55,212‐2, but not WIN55,212‐3, administered i.t. suppressed vincristine‐evoked mechanical hypersensitivity at doses that were inactive following local hindpaw administration. Spinal coadministration of both the CB 1 and CB 2 antagonists blocked the anti‐allodynic effects of WIN55,212‐2. Conclusions and implications: Cannabinoids suppress the maintenance of vincristine‐induced mechanical allodynia through activation of CB 1 and CB 2 receptors. These anti‐allodynic effects are mediated, at least in part, at the level of the spinal cord. British Journal of Pharmacology (2007) 152, 765–777; doi:10.1038/sj.bjp.0707333; published online 18 June 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These effects were blocked by intrathecal co-administration of rimonabant and SR144528, implicating both CB 1 and CB 2 receptors (Rahn et al, 2007).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Rahn et al, 2007
In the citing paper
“In particular, systemic administration of WIN55,212-2 suppresses vincristine-evoked mechanical allodynia through a CB 1 and CB 2 -dependent mechanism.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Rahn et al, 2007
In the citing paper
“Spinal administration of WIN55,212-2 suppressed vincristineevoked mechanical hypersensitivity at doses that were inactive following intraplantar administration.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Rahn et al, 2007
In the citing paper
“In addition, AM1241 reverses vincristine-induced mechanical hypersensitivity through a CB 2 receptor mechanism of action.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Rahn et al, 2007
In the citing paper
“Mixed CB 1 /CB 2 receptor agonists and CB 2 selective receptor agonists reduce nociceptive behavior in vincristine-treated rats (Rahn et al, 2007) (see Table 5).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Rahn et al, 2007
In the citing paper
“Systemic and intrathecal, but not intraplantar, WIN55,212-2 suppressed vincristine-induced mechanical allodynia through activation of CB1 and CB2 receptors.122”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [122]
In the citing paper
“Systemic (R,S)-AM1241 also partially reversed vincristine-induced mechanical allodynia in a CB2-dependent manner.122”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [122]
In the citing paper
“The anti-allodynic effects of WIN55,212-2 and (R,S)-AM1241 were observed at doses that did not produce intrinsic effects on motor behavior in the bar test.122”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ethical guidelines for investigations of experimental pain in conscious animals.
Zimmermann, M. (1983) · Pain · doi:10.1016/0304-3959(83)90201-4 · Cited by 7,762
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R. A., Brown, F. J., Flores, C., & Joris, J. L. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,155
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Chronic catheterization of the spinal subarachnoid space
Yaksh, T. L., & Rudy, T. A. (1976) · Physiology & Behavior · doi:10.1016/0031-9384(76)90029-9 · Cited by 2,197
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Self-citationIncreased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Self-citationCannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Mackie, K., & Hille, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3825 · Cited by 700
Mackie, K., Lai, Y. Y., Westenbroek, R. E., & Mitchell, R. A. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 635
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 581
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy
Flatters, S. J. L., & Bennett, G. J. (2004) · Pain · doi:10.1016/j.pain.2004.01.029 · Cited by 576
Cited by
Sorted by citations
Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423
Self-citationCannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 440
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305
Self-citationDonvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301
Cannabinoids in the management of difficult to treat pain
Russo, E. B. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1928 · Cited by 300
Ward, S. J., McAllister, S. D., Kawamura, R., Murase, R., Neelakantan, H., & Walker, E. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12439 · Cited by 287
Lynch, M. E., Cesar-Rittenberg, P., & Hohmann, A. G. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.02.018 · Cited by 266
Self-citationCytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management
Vanderwall, A. G., & Milligan, E. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03009 · Cited by 227
Deng, L., Guindon, J., Cornett, B., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.009 · Cited by 200
Self-citationThe Role of the Endocannabinoid System in Pain
Woodhams, S. G., Sagar, D. R., Burston, J. J., & Chapman, V. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_7 · Cited by 216
Sciolino, N. R., Zhou, W., & Hohmann, A. G. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.04.010 · Cited by 179
Self-citationKinsey, S. G., Wise, L. E., Ramesh, D., Abdullah, R., Selley, D. E., Cravatt, B. F., & Lichtman, A. H. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201426 · Cited by 169
Guindon, J., Lai, Y., Takacs, S. M., Bradshaw, H. B., & Hohmann, A. G. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.013 · Cited by 160
Self-citationKing, K. M., Myers, A. M., Soroka‐Monzo, A. J., Tuma, R. F., Tallarida, R. J., Walker, E. A., & Ward, S. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13887 · Cited by 156
The analgesic potential of cannabinoids.
Elikottil, M., Gupta, M., & Gupta, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0034 · Cited by 141
Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies
Authier, N., Balayssac, D., Marchand, F., Ling, B., Zangarelli, A., Descoeur, J., Coudoré, F., Bourinet, E., & Eschalier, A. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.07.003 · Cited by 120
Rahn, E. J., Zvonok, A. M., Thakur, G. A., Khanolkar, A. D., Makriyannis, A., & Hohmann, A. G. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141994 · Cited by 116
Self-citationCB1 Cannabinoid Receptor Signaling and Biased Signaling
Leo, L. M., & Abood, M. E. (2021) · Molecules · doi:10.3390/molecules26175413 · Cited by 121
Integrating Cannabis into Clinical Cancer Care
Abrams, D. I. (2016) · Current Oncology · doi:10.3747/co.23.3099 · Cited by 115
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice
Segat, G. C., Manjavachi, M. N., Matias, D. O., Passos, G. F., Freitas, C. S., da Costa, R., & Calixto, J. Β. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.015 · Cited by 113
Deng, L., Guindon, J., Vemuri, V. K., Thakur, G. A., White, F. A., Makriyannis, A., & Hohmann, A. G. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-71 · Cited by 94
Self-citationOpportunities for cannabis in supportive care in cancer
Kleckner, A. S., Kleckner, I. R., Kamen, C. S., Tejani, M. A., Janelsins, M. C., Morrow, G. R., & Peppone, L. J. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919866362 · Cited by 92
Lal, S., Shekher, A., Puneet, Narula, A. S., Abrahamse, H., & Gupta, S. C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105302 · Cited by 91
Naguib, M., Diaz, P., Xu, J. J., Astruc‐Diaz, F., Craig, S., Vivas‐Mejia, P., & Brown, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.340 · Cited by 82
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 81
Dynamic changes to the endocannabinoid system in models of chronic pain
Sagar, D. R., Burston, J. J., Woodhams, S. G., & Chapman, V. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0390 · Cited by 77
Opioid and cannabinoid synergy in a mouse neuropathic pain model
Kazantzis, N. P., Casey, S. L., Seow, P. W., Mitchell, V. A., & Vaughan, C. W. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13534 · Cited by 71
Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain
Gutierrez, T., Crystal, J. D., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2011) · Pain · doi:10.1016/j.pain.2011.03.038 · Cited by 71
Self-citationCannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain
Blanton, H. L., Brelsfoard, J., Deturk, N., Pruitt, K., Narasimhan, M., Morgan, D. J., & Guindon, J. (2019) · Drugs · doi:10.1007/s40265-019-01132-x · Cited by 71
Chapter 14 Involvement of Inflammatory Mediators in Neuropathic Pain Caused by Vincristine
Kiguchi, N., Maeda, T., Kobayashi, Y., Saika, F., & Kishioka, S. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)85014-9 · Cited by 70
Use of Cannabis and Cannabinoids for Treatment of Cancer
Cherkasova, V., Wang, B., Gerasymchuk, M., Fiselier, A., Kovalchuk, O., & Kovalchuk, I. (2022) · Cancers · doi:10.3390/cancers14205142 · Cited by 70
Vera, G., Cabezos, P. A., Martín, M. I., & Abalo, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.02.008 · Cited by 68
Ling, B., Coudoré, F., Decalonne, L., Eschalier, A., & Authier, N. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.007 · Cited by 67
Gamaleddin, I., Zvonok, A. M., Makriyannis, A., Goldberg, S. R., & Foll, B. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029900 · Cited by 66
Self-citationRahn, E. J., Deng, L., Thakur, G. A., Vemuri, K. V., Zvonok, A. M., Lai, Y. Y., Makriyannis, A., & Hohmann, A. G. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-27 · Cited by 65
Self-citationMulpuri, Y., Marty, V. N., Munier, J. J., Mackie, K., Schmidt, B. L., Seltzman, H. H., & Spigelman, I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.002 · Cited by 62
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1560-2_18 · Cited by 62
Self-citationMakriyannis, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500220s · Cited by 61
Self-citationCannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
Campos, R. M. P., Aguiar, A. F. L., Paes-Colli, Y., Trindade, P. M. P., Ferreira, B. K., Reis, R. A. D. M., & Sampaio, L. D. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.785176 · Cited by 59
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
Abrams, D. I. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221081772 · Cited by 61
Rahn, E. J., Thakur, G. A., Wood, J. A. T., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.024 · Cited by 57
Self-citationRole of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 59
The pharmacological management of dental pain
Pergolizzi, J. V., Magnusson, P., LeQuang, J. A., Gharibo, C. G., & Varrassi, G. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1718651 · Cited by 53
Wilkerson, J. L., Gentry, K. R., Dengler, E. C., Wallace, J. A., Kerwin, A. A., Kuhn, M. N., Zvonok, A. M., Thakur, G. A., Makriyannis, A., & Milligan, E. D. (2012) · Brain and Behavior · doi:10.1002/brb3.44 · Cited by 51
Self-citationThe central cannabinoid receptor type-2 (CB2) and chronic pain
Shang, Y.-C., & Tang, Y. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1257992 · Cited by 51
Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041423 · Cited by 54
Wala, E. P., Crooks, P. A., McIntosh, J. M., & Holtman, J. R. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31825a3c72 · Cited by 43
Effect of Chronic Pain on Fentanyl Self-Administration in Mice
Wade, C. L., Krumenacher, P., Kitto, K. F., Peterson, C. D., Wilcox, G. L., & Fairbanks, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079239 · Cited by 43
Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-Induced Neuropathic Pain in Rodents
Kalvala, A. K., Bagde, A., Arthur, P., Surapaneni, S. K., Nimma, R., Nathani, A., & Singh, M. S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108693 · Cited by 43
Reddy, V. P., Grogan, D. P., Ahluwalia, M., Salles, É. L., Ahluwalia, P. K., Khodadadi, H., Alverson, K., Nguyen, A., Raju, S. P., Gaur, P., et al. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00203-4 · Cited by 45
Microglial Cannabinoid CB2 Receptors in Pain Modulation
Xu, K., Wu, Y., Tian, Z., Xu, Y., Wu, C., & Wang, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032348 · Cited by 43
Vera, G., López‐Miranda, V., Herradón, E., Martı́n, M. I., & Abalo, R. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.05.008 · Cited by 41
Role of sensory nerves in gastroprotective effect of anandamide in rats.
Warzecha, Z., DEMBINSKI, A. B., Ceranowicz, P., Dembiński, M., Cieszkowski, J., Kownacki, P., & Konturek, P. C. (2011) · PubMed · Cited by 41
Park, B. Y., Park, S. H., Kim, W. M., Yoon, M. H., & Lee, H. G. (2010) · The Korean journal of pain · doi:10.3344/kjp.2010.23.3.179 · Cited by 37
Masocha, W. (2018) · Pain Research and Management · doi:10.1155/2018/5234943 · Cited by 37
Cannabis for Pain and Headaches: Primer
Kim, P. S., & Fishman, M. A. (2017) · Current Pain and Headache Reports · doi:10.1007/s11916-017-0619-7 · Cited by 36
Furuse, S., Kawamata, T., Yamamoto, J., Niiyama, Y., Omote, K., Watanabe, M., & Namiki, A. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a51e0d · Cited by 37
Ghovanloo, M., Estación, M., Higerd‐Rusli, G. P., Zhao, P., Dib‐Hajj, S. D., & Waxman, S. G. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15833 · Cited by 33
Wu, B.-Y., Liu, C., Su, Y., Chen, S., Chen, Y., & Tsai, M.-Y. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.022 · Cited by 33
Repetti, C. S. F., Gírio, R. J. S., Friolani, M., & Barbalho, S. M. (2019) · Ciência Rural · doi:10.1590/0103-8478cr20180595 · Cited by 38
Nutraceuticals: A source of benefaction for neuropathic pain and fibromyalgia
Mishra, G., Singh, P. N. D., Molla, M., Yimer, Y. S., Ewunetie, A., Tadesse, T. Y., Ayele, T. M., & Kefale, B. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105260 · Cited by 32
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
Tamba, B.-I., Stanciu, G. D., Urîtu, C. M., Rezuş, E., Ştefănescu, R., Mihai, C. T., Luca, A., Rusu-Zota, G., Leon, M. M., Cojocaru, E., et al. (2020) · Medicina · doi:10.3390/medicina56010024 · Cited by 32
Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice
Linglu, D., Li, Y., Xu, Y., Ru, Z., Ma, L., Shaoju, J., Du, J., Sun, T., & Yu, J. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1603-6 · Cited by 31
Thomas, A., Okine, B. N., Finn, D. P., & Masocha, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110456 · Cited by 32
Bhalla, S., Singh, N., & Jaggi, A. S. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.02.016 · Cited by 29
Henderson, A. N., Crawford, L. C., Sepúlveda, D. E., Hale, D. E., Lesperance, J., & Morgan, D. J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.684115 · Cited by 31
Łuszczki, J. J., & Florek-Łuszczki, M. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70867-8 · Cited by 28
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
Cabañero, D., Martín‐García, E., & Maldonado, R. J. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1971196 · Cited by 30
Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat
Abalo, R., Cabezos, P. A., Vera, G., López-Pérez, A. E., & Martı́n, M. I. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12073 · Cited by 28
Abalo, R., Chen, C., Vera, G., Fichna, J., Thakur, G. A., López-Pérez, A. E., Makriyannis, A., Martı́n, M. I., & Storr, M. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12668 · Cited by 28
Self-citationTopical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series
D’Andre, S. D., McAllister, S. D., Nagi, J., Giridhar, K. V., Ruiz-Macias, E., & Loprinzi, C. L. (2021) · Integrative Cancer Therapies · doi:10.1177/15347354211061739 · Cited by 27
Should Oncologists Recommend Cannabis?
Abrams, D. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0659-9 · Cited by 22
Casey, S. L., Mitchell, V. A., Sokolaj, E. E., Winters, B. L., & Vaughan, C. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158649 · Cited by 29
Sadaka, A. H., Canuel, J., Febo, M., Johnson, C. T., Bradshaw, H. B., Ortiz, R. J., Ciumo, F., Kulkarni, P., Gitcho, M. A., & Ferris, C. F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1055433 · Cited by 25
Abalo, R., Cabezos, P. A., Vera, G., Fernández‐pujol, R., & Martı́n, M. I. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01466.x · Cited by 26
Alkislar, I., Miller, A. R., Hohmann, A. G., Sadaka, A. H., Cai, X., Kulkarni, P., & Ferris, C. F. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.11.015 · Cited by 24
Self-citationAlmaraz, E. R., & Butowski, N. A. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-01047-y · Cited by 25
Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review
Schloss, J. M., Colosimo, M. L., & Vitetta, L. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.889081 · Cited by 23
Update on cannabis and cannabinoids for cancer pain
Chung, M. J., Kim, H. K., & Abdi, S. (2020) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000934 · Cited by 24
Reduction of bone cancer pain by CB1 activation and TRPV1 inhibition
Kawamata, T., Niiyama, Y., Yamamoto, J., & Furuse, S. (2010) · Journal of Anesthesia · doi:10.1007/s00540-010-0919-0 · Cited by 22
Slivicki, R. A., Ali, Y., Lu, H., & Hohmann, A. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147620 · Cited by 22
Self-citationOstadhadi, S., Rahmatollahi, M., Dehpour, A. R., & Rahimian, R. (2014) · Phytotherapy Research · doi:10.1002/ptr.5265 · Cited by 19
Chronic pain and cannabinoids. Great expectations or a christmas carol
Pascual, D., Sánchez-Robles, E., García, M. M., & Goicoechea, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.033 · Cited by 22
Lee, G., & Kim, S. K. (2016) · Molecules · doi:10.3390/molecules21091252 · Cited by 21
Arena, C., Gado, F., Mannelli, L. D. C., Cervetto, C., Carpi, S., Reynoso-Moreno, I., Polini, B., Vallini, E., Chicca, S., Lucarini, E., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112858 · Cited by 21
Bagüés, A., López‐Tofiño, Y., Llorente‐Berzal, A., & Abalo, R. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000667 · Cited by 18
Goel, Y., Fouda, R., & Gupta, K. (2022) · Antioxidants · doi:10.3390/antiox11020265 · Cited by 16
Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
Safi, K., Sobieraj, J., Błaszkiewicz, M., Żyła, J., Salata, B., & Dzierżanowski, T. (2024) · Biomedicines · doi:10.3390/biomedicines12020307 · Cited by 21
Alterations in the Anandamide Metabolism in the Development of Neuropathic Pain
Małek, N., Kucharczyk, M. W., & Starowicz, K. (2014) · BioMed Research International · doi:10.1155/2014/686908 · Cited by 19
Spyridakos, D., Papadogkonaki, S., Dionysopoulou, S., Mastrodimou, N., Polioudaki, H., & Thermos, K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104907 · Cited by 17
Do cannabinoids have a role in cancer pain management?
Farquhar-Smith, W. P. (2009) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3283260612 · Cited by 15
Kim, K., Jeong, W., Jun, I., & Park, J. Y. (2020) · Korean Journal of Anesthesiology · doi:10.4097/kja.19481 · Cited by 15
Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence
Sokolaj, E. E., Assareh, N., Anderson, K. E., Aubrey, K. R., & Vaughan, C. W. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15964 · Cited by 16
Suppressive Effect of Imipramine on Vincristine-Induced Mechanical Allodynia in Mice
Saika, F., Kiguchi, N., Kobayashi, Y., Fukazawa, Y., Maeda, T., Ozaki, M., & Kishioka, S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1231 · Cited by 14
Ghovanloo, M.-R., Effraim, P. R., Tyagi, S., Zhao, P., Dib-Hajj, S., & Waxman, S. (2024) · Communications Biology · doi:10.1038/s42003-024-05781-x · Cited by 15
The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects
Shalata, W., Saleh, O. A., Tourkey, L., Shalata, S., Neime, A. E., Abu‐Juma, A., Soklakova, A., Tourkey, L., Jama, A. A., & Yakobson, A. (2024) · Cancers · doi:10.3390/cancers16162909 · Cited by 13
Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
Guenther, K. G., & Hohmann, A. G. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70116 · Cited by 12
Self-citationEmerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models
Morales, P., & Reggio, P. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_4 · Cited by 13
Gorzo, A., Havasi, A. D., Spînu, Ș., Oprea, A. L., Burz, C. C., & Sur, D. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175036 · Cited by 13
Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies
Irrera, N., Bitto, A., Sant’Antonio, E., Lauro, R., Musolino, C., & Allegra, A. (2021) · Molecules · doi:10.3390/molecules26133866 · Cited by 12
Metadata
- Authors
- Rahn, E. J., Makriyannis, A., & Hohmann, A. G.
- Affiliations
- University of Georgia (US)
- Northeastern University (US)
- Corresponding author
- Hohmann, A G
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-11
- Volume
- 152
- Issue
- 5
- Pages
- 765-777
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2190028
- OpenAlex
- W1542530495
- Cited by
- 146
- References
- 70
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 15 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 6 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 11
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Psi Chi
- American Psychological Association of Graduate Students
- National Institute on Drug Abuse (DA3801, DA022478, DA 9158, R01DA003801, R21DA022478, R01DA021644, R01DA014022, R37DA003801, DA014022, P01DA009158, DA021644)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- CB1 receptor, CB2 receptor, vincristine, chemotherapy-induced peripheral neuropathy, mechanical allodynia, neuropathic pain, WIN 55,212-2, SR141716, SR144528, morphine, spinal cord, intrathecal administration
- MeSH terms
- Rimonabant, Animals, Body Weight, Camphanes, Cannabinoids, Catalepsy, Dose-Response Relationship, Drug, Hindlimb, Hyperesthesia, Injections, Intraperitoneal, Injections, Spinal, Male, Morphine, Morpholines, Naphthalenes, Neuralgia, Pain Measurement, Physical Stimulation, Piperidines, Pyrazoles, Thermosensing, Vincristine, Rats, Sprague-Dawley, Pain Threshold, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Benzoxazines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
